Myriad Genetics, Inc.MYGNNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank67
3Y CAGR-50.2%
Year-over-Year Change
Year-over-year gross profit growth rate
3Y CAGR
-50.2%/yr
Quarterly compound
Percentile
P67
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 2.09% |
| Q3 2025 | -5.27% |
| Q2 2025 | 13.11% |
| Q1 2025 | -11.07% |
| Q4 2024 | 0.73% |
| Q3 2024 | 1.84% |
| Q2 2024 | 6.90% |
| Q1 2024 | 1.93% |
| Q4 2023 | 0.52% |
| Q3 2023 | 6.84% |
| Q2 2023 | 3.03% |
| Q1 2023 | -1.53% |
| Q4 2022 | 16.89% |
| Q3 2022 | -18.21% |
| Q2 2022 | 10.86% |
| Q1 2022 | 1.65% |
| Q4 2021 | -3.77% |
| Q3 2021 | -11.94% |
| Q2 2021 | 10.50% |
| Q1 2021 | 0.00% |
| Q4 2020 | -100.00% |
| Q3 2020 | 78.76% |
| Q2 2020 | -50.40% |
| Q1 2020 | -21.72% |
| Q4 2019 | 6.52% |
| Q3 2019 | -17.11% |
| Q2 2019 | -1.90% |
| Q1 2019 | 2.00% |
| Q4 2018 | 7.93% |
| Q3 2018 | -1.68% |
| Q2 2018 | 3.88% |
| Q1 2018 | -0.13% |
| Q4 2017 | 1.63% |
| Q3 2017 | -6.84% |
| Q2 2017 | 3.54% |
| Q1 2017 | 0.33% |
| Q4 2016 | 10.62% |
| Q3 2016 | -6.14% |
| Q2 2016 | -2.53% |
| Q1 2016 | -1.57% |